Emergence and disappearance of W135 meningococcal disease

Epidemiology and Infection

Volumn 138, Issue 7, 2010, Pages 976-978

  Wilder Smith, A ^a   Chow, A ^b   Goh, K T ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c MINISTRY OF HEALTH   (Singapore)

Author keywords

Hajj pilgrims; Household contacts; Importation; Non Hajj related

Indexed keywords

ANTIBIOTIC AGENT; MENINGOCOCCUS VACCINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; COMMUNITY; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; HOUSEHOLD; HUMAN; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; SEROTYPE; SINGAPORE; VACCINATION;

DISEASE OUTBREAKS; HUMANS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS, SEROGROUP W-135; SINGAPORE;

EID: 77953621761     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880999104X     Document Type: Article

References (12)

1. Taha MK, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000; 356: 2159.
2. Doganci L, et al. Neisseria meningitidis W135, Turkey. Emerging Infectious Diseases 2004; 10: 936-937.
3. Fonkoua MC, et al. Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaounde, Cameroon. Emerging Infectious Diseases 2002; 8: 327-329.
4. Hahne SJ, et al. W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet 2002; 359: 582-583.
5. Koumare B, et al. The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. Vaccine 2007; 25 (Suppl. 1): A37-41.
6. Wilder-Smith A, et al. Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study. British Medical Journal 2002; 325: 365-366.
7. Wilder-Smith A, et al. Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts. Emerging Infectious Diseases 2003; 9: 123-126.
8. Wilder-Smith A, et al. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clinical Infectious Diseases 2003; 36: 679-683.
9. Wilder-Smith A, Tai Goh K. W-135 meningococcal disease in a traveler : a case report. Journal of Travel Medicine 2003; 10: 59-60.
10. Jodar L, et al. Development of vaccines against meningococcal disease. Lancet 2002; 359: 1499-1508.
11. Ahmed QA, et al. Health risks at the Hajj. Lancet 2006; 367: 1008-1015.
12. Wilder-Smith A, et al. Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002. Emerging Infectious Diseases 2003; 9: 734-737.